UK
UK
Apr-17
Cardiovascular Pharmacoepidemiology
Read moreMar-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMar-17
Cardiovascular Pharmacoepidemiology
Read moreMar-17
Mar-17
Mar-17
Mental Health Pharmacoepidemiology
Read moreMar-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMar-17
Endocrinology Pharmacoepidemiology
Read moreFeb-17
Gastroenterology Pharmacoepidemiology
Read moreFeb-17
| Date | Title | Categories | |
|---|---|---|---|
| Apr-17 | Use of azithromycin and risk of ventricular arrhythmia | Read more | |
| Mar-17 | Adding a Glucagon like peptide‐1 analogue (GLP‐1RA) has a favourable effect on mortality and cardiovascular events among insulin‐treated patients with Type 2 diabetes: a large retrospective UK cohort study | Read more | |
| Mar-17 | Lower Rates of Hospitalization for Heart Failure and All-Cause Death in New Users of SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs – Real World Data from Six Countries and More Than 300,000 Patients: the CVD-REAL Study | Read more | |
| Mar-17 | Sodium‐glucose cotransporter 2 inhibitiors and death from any cause in a real world setting | Read more | |
| Mar-17 | Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network | Read more | |
| Mar-17 | Statin prescribing for people with severe mental illnesses: a staggered cohort study of ‘real-world’ impacts | Read more | |
| Mar-17 | Obesity as a predictor of five year cardiovascular (CV) outcomes and mortality in patients with Type 2 diabetes started on insulin therapy: real world evidence in UK primary care | Read more | |
| Mar-17 | Effectiveness of liraglutide and lixisenatide in the treatment of Type 2 diabetes: real world evidence from The Health Improvement Network (THIN) database in the United Kingdom (UK) | Read more | |
| Mar-17 | Glucagon‐like peptide 1 agonists and death from any cause in primary care setting | Read more | |
| Feb-17 | Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding | Read more | |
| Feb-17 | Proton pump inhibitors on pancreatic cancer risk and survival | Read more | |
| Feb-17 | Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines | Read more |
